Literature DB >> 3019343

Synergistic action of adenosine and fMet-Leu-Phe in raising cAMP content of purified human monocytes.

K R Elliott, P J Miller, H C Stevenson, E J Leonard.   

Abstract

The content of cAMP was measured in monocytes treated with fMet-Leu-Phe and adenosine, either singly or in combination. Adenosine caused a small and variable rise in cAMP, which was considerably less than that caused by fMet-Leu-Phe. The rise induced by peptide plus adenosine was twice the sum of the increases caused by each agent alone. An inhibitor of phosphodiesterase also enhanced the adenosine-induced rise in cAMP. The data suggest that the increase in cAMP by adenosine-induced cyclase activation is limited by the activity of phosphodiesterase, and that the latter can be inhibited by fMet-Leu-Phe.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019343     DOI: 10.1016/s0006-291x(86)80435-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Dynamics of chemotactic peptide-induced superoxide generation by human monocytes.

Authors:  E J Leonard; A Shenai; A Skeel
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

2.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Authors:  B N Cronstein; M A Eberle; H E Gruber; R I Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization.

Authors:  B N Cronstein; S B Kramer; E D Rosenstein; H M Korchak; G Weissmann; R Hirschhorn
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

4.  Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy.

Authors:  Eduardo Monguilhott Dalmarco; Tânia Silvia Fröde; Yara Santos Medeiros
Journal:  Mediators Inflamm       Date:  2002-10       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.